Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001580 · ClinicalTrials.gov registry record
Tissue Acquisition for Molecular Diagnostics
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 50
- Enrollment target
NCT00001580: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001580 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001580 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Acquisition of fresh tumor and normal tissue samples are necessary for the preparation of cDNA libraries, microarray chips, and tissue specific probes, and proteomics development and validation. This protocol will allow acquisition of samples at the time of tissue sampling for surgery, diagnostic tests, or therapeutic phereses. These samples will be forwarded without patient identifiers, pathology reports, or other labels. Tissue pathology will be verified within the Laboratory of Pathology and samples used strictly for CGAP and Proteomic Initiative indications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1997-06 |
| Est. Completion | 2003-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001580
The ClinicalTrials.gov registry entry for NCT00001580 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001580 about?
NCT00001580 is a clinical study titled "Tissue Acquisition for Molecular Diagnostics". Acquisition of fresh tumor and normal tissue samples are necessary for the preparation of cDNA libraries, microarray chips, and tissue specific probes, and proteomics development and validation. This protocol will allow acquisition of samples at the time of tissue sampling for surgery, diagnostic te...
What is the current status of trial NCT00001580?
This trial is currently completed. The enrollment target is 50 participants. The study started on 1997-06. Estimated completion is 2003-03.
Who is sponsoring clinical trial NCT00001580?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.